2025-05-17 - Analysis Report
Okay, here's a comprehensive analysis of Philip Morris International Inc. (PM), presented in English with concise numerical summaries and interpretations.

## Philip Morris International Inc. (PM) Stock Analysis

**Company Overview:** Philip Morris International Inc. (PM) is a leading international tobacco company engaged in the manufacture and sale of cigarettes, smokeless tobacco, and related products.

### 1. Performance vs. S&P 500 (VOO)

*   **PM Cumulative Return:** 83.39%
*   **VOO Cumulative Return:** 84.12%
*   **Performance Difference (Current):** -0.7%
*   **Performance Difference Range (Max: 25.8%, Min: -59.7%)**
*   **Relative Performance Position:** 69.0 (Indicates PM is positioned at the 69th percentile relative to its historical performance compared to VOO within the defined range.)

**Analysis:** PM's cumulative return is slightly lagging behind the S&P 500 (VOO) by 0.7%. The relative performance position of 69.0 suggests that PM is currently performing closer to its higher historical range compared to VOO, but is not outperforming it.

**Alpha/Beta Analysis Table:**

| Year       | CAGR   | MDD    | Alpha   | Beta  | Cap(B) |
|------------|--------|--------|---------|-------|--------|
| 2015-2017  | 24.0%  | 4.9%   | -5.0%   | -0.0  | 111.2  |
| 2016-2018  | -19.0% | 59.7%  | -36.0%  | 0.0   | 74.2   |
| 2017-2019  | 5.0%   | 59.7%  | -24.0%  | 0.2   | 100.1  |
| 2018-2020  | 1.0%   | 63.7%  | -25.0%  | 1.2   | 103.8  |
| 2019-2021  | 35.0%  | 63.7%  | -20.0%  | 1.7   | 125.4  |
| 2020-2022  | 28.0%  | 63.7%  | 22.0%   | 1.7   | 140.8  |
| 2021-2023  | 13.0%  | 70.4%  | -4.0%   | 0.6   | 138.2  |
| 2022-2024  | 4.0%   | 70.4%  | -12.0%  | 0.5   | 185.7  |
| 2023-2025  | 41.0%  | 73.8%  | 9.0%    | 0.3   | 265.3  |

**Analysis:**

*   **CAGR:** Varies significantly across periods, indicating fluctuating growth rates.
*   **MDD:** High Maximum Drawdown figures suggest periods of significant volatility.
*   **Alpha:** PM often underperforms the benchmark (negative Alpha).
*   **Beta:** Beta values are generally low, suggesting PM's price is less sensitive to market movements.
*   **Cap(B):** Market capitalization has generally increased over the periods examined.

### 2. Recent Stock Price Movements

*   **Current Price:** $170.44
*   **Previous Close:** $169.14
*   **Change:** 0.77
*   **5-Day Moving Average:** 166.45
*   **20-Day Moving Average:** 169.15
*   **60-Day Moving Average:** 158.95

**Analysis:** The current price is above the 5-day and 20-day moving averages, suggesting a short-term upward trend. The price is also significantly above the 60-day moving average, indicating a longer-term positive trend. The recent price change suggests a slight upward movement.

### 3. Market Risk Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3475 (Low Risk)
*   **RSI:** 52.35 (Neutral)
*   **PPO:** -0.58
*   **Recent (20-Day) Relative Performance Change:** -15.7 (Short-term decline)
*   **Expected Return:** -12.9% (Long-term underperformance vs. S&P 500)

**Analysis:** The MRI indicates a low-risk market environment for PM.  The RSI is neutral. The negative PPO suggests a slight downward momentum. The recent relative performance change indicates a short-term decline compared to the benchmark. The negative expected return suggests that PM is projected to underperform the S&P 500 over a long-term investment horizon (2+ years).  The notable price change of 0.77 (given the context of previous close) warrants attention, potentially signaling market reaction to news or events.

### 4. Recent News & Significant Events

*   **May 14, 2025:** Major business developments, regulatory changes, or market events.
*   **May 16, 2025:** Analysts discussing recent performance and outlook.
*   **May 15, 2025:** Notable stock volatility.
*   **May 17, 2025:** Market experts highlighting risks and opportunities.

**Analysis:** Recent news suggests significant activity around PM, including volatility, analyst discussions, and potential business or regulatory changes. Investors should monitor news and company announcements closely.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-04-24 | 1.72 | $9.30B       |
| 2024-10-24 | 1.98 | $9.91B       |
| 2024-07-25 | 1.54 | $9.47B       |
| 2024-04-26 | 1.38 | $8.79B       |
| 2025-04-24 | 1.38 | $8.79B       |

**Analysis:**

*   EPS has fluctuated over the recent quarters.
*   Revenue shows a similar pattern, with no clear upward or downward trend.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $9.30B   | 67.32%        |
| 2024-12-31 | $9.71B   | 64.73%        |
| 2024-09-30 | $9.91B   | 66.04%        |
| 2024-06-30 | $9.47B   | 64.67%        |
| 2024-03-31 | $8.79B   | 63.66%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE       |
|------------|------------|-----------|
| 2025-03-31 | $-10.90B  | -24.68%   |
| 2024-12-31 | $-11.75B  | 4.93%     |
| 2024-09-30 | $-9.69B   | -31.79%   |
| 2024-06-30 | $-9.74B   | -24.69%   |
| 2024-03-31 | $-10.31B  | -20.84%   |

**Analysis:**

*   **Revenue:** Shows some fluctuation, peaking in 2024-09-30.
*   **Profit Margin:** Relatively stable, indicating consistent profitability.
*   **Equity:** Negative equity is a concern and requires further investigation.
*   **ROE:** Highly volatile, with negative values indicating poor returns on equity.

### 7. Overall Analysis & Summary

Philip Morris International (PM) exhibits a mixed performance profile. While recent price action suggests a short-term upward trend, the company is slightly underperforming the S&P 500. The MRI indicates low market risk, but the negative expected return suggests potential long-term underperformance compared to the benchmark.

Key concerns include:

*   Negative equity and volatile ROE.
*   Inconsistent revenue and EPS growth.
*   Potential business or regulatory changes.

**Recommendation:** Exercise caution.  Thoroughly investigate the negative equity and ROE figures. Monitor news and analyst reports closely, considering the potential impacts of recent events and industry trends.
